论文部分内容阅读
冠心病是多危险因子所致的慢性病,发病率呈逐年上升趋势,老年人群中的发病率达到30%。动脉粥样硬化血栓形成是导致冠心病病人发生临床急症的病理基础。其中血小板是体内参与血栓形成的最主要成分,在粥样硬化血栓形成过程中血小板活化和聚集起核心作用。因此,采取合理的抗血小板治疗有助于减少临床心血管不良事件的发生率。我们调查了部分老年患者应用抗血小板药物的情况,现报告如下。
Coronary heart disease is a chronic disease caused by multiple risk factors. The incidence is increasing year by year, and the incidence in the elderly population reaches 30%. Atherothrombosis is the pathological basis of clinical emergency in patients with coronary heart disease. Platelets are the major components involved in thrombosis in vivo and play a central role in the activation and aggregation of platelets during atherothrombosis. Therefore, taking reasonable antiplatelet therapy can help reduce the incidence of clinical cardiovascular adverse events. We investigated the use of anti-platelet drugs in some elderly patients and are reported below.